Indeed, anti-miR-21 has been found to reduce VEGF levels and tumor vascularization in some studies of liver cancer and chronic liver disease, suggesting improved oxygenation and drug delivery in the treated tumor [115]. The gene discussed is VEGFA; the disease is neoplasm.